PAD. ICORG 05-01, V11

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2012

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

Bortezomib

DRUG

Doxorubicin

DRUG

Dexamethasone

Trial Locations (9)

7

Mater Misericordiae University Hospital, Dublin

8

St. James's Hospital, Dublin

24

Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin

Unknown

University College Hospital, Galway

0009

Mid-Western Cancer Centre at Mid-Western Regional Hospital, Limerick

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

EC1A 7BE

Saint Bartholomew's Hospital, London

NW1 2BU

University College Hospital, London

BT9 7AB

Belfast City Hospital Trust Incorporating Belvoir Park Hospital, Belfast

All Listed Sponsors
lead

Cancer Trials Ireland

NETWORK

NCT00814541 - PAD. ICORG 05-01, V11 | Biotech Hunter | Biotech Hunter